IL136137A0 - Hydrophobically-modified protein compositions and methods - Google Patents

Hydrophobically-modified protein compositions and methods

Info

Publication number
IL136137A0
IL136137A0 IL13613798A IL13613798A IL136137A0 IL 136137 A0 IL136137 A0 IL 136137A0 IL 13613798 A IL13613798 A IL 13613798A IL 13613798 A IL13613798 A IL 13613798A IL 136137 A0 IL136137 A0 IL 136137A0
Authority
IL
Israel
Prior art keywords
protein
hydrophobically
methods
hydrophobic moiety
modified protein
Prior art date
Application number
IL13613798A
Other languages
English (en)
Original Assignee
Biogen Inc
Ontogeny Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Ontogeny Inc filed Critical Biogen Inc
Publication of IL136137A0 publication Critical patent/IL136137A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13613798A 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods IL136137A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods

Publications (1)

Publication Number Publication Date
IL136137A0 true IL136137A0 (en) 2001-05-20

Family

ID=27490628

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13613798A IL136137A0 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Country Status (25)

Country Link
US (1) US6444793B1 (pl)
EP (1) EP1036092B1 (pl)
JP (1) JP4289788B2 (pl)
KR (1) KR20010032753A (pl)
CN (1) CN1294595A (pl)
AT (1) ATE295372T1 (pl)
AU (1) AU757497B2 (pl)
BR (1) BR9815142A (pl)
CA (1) CA2309806A1 (pl)
CZ (1) CZ20002008A3 (pl)
DE (1) DE69830192T2 (pl)
DK (1) DK1036092T3 (pl)
EA (1) EA003739B1 (pl)
EE (1) EE200000308A (pl)
ES (1) ES2243018T3 (pl)
HU (1) HUP0100535A3 (pl)
IL (2) IL136137A0 (pl)
IS (1) IS2163B (pl)
MX (1) MXPA00005494A (pl)
NO (1) NO20002789L (pl)
NZ (1) NZ504752A (pl)
PL (1) PL197833B1 (pl)
PT (1) PT1036092E (pl)
TR (1) TR200001612T2 (pl)
WO (1) WO1999028343A2 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034269A1 (en) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
KR20010032753A (ko) 1997-12-03 2001-04-25 온토제니, 인코오포레이티드 소수적으로 개질된 단백질 조성물 및 방법
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP0953576B1 (en) * 1998-04-30 2005-11-02 Curis, Inc. Active hedgehog protein conjugate, process for its production and use
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
ATE404583T1 (de) * 1998-11-02 2008-08-15 Curis Inc Funktionelle antagonisten von hedgehog-aktivität
IL143403A0 (en) * 1998-12-03 2002-04-21 Biogen Inc Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
JP2003502292A (ja) * 1999-06-01 2003-01-21 バイオジェン インコーポレイテッド ヘッジホッグタンパク質のポリマー結合体及び利用
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
AU780693B2 (en) * 1999-11-05 2005-04-14 Curis, Inc. Hedgehog fusion proteins and uses
WO2001082994A1 (en) * 2000-04-28 2001-11-08 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
AU2003225085A1 (en) * 2002-04-19 2003-11-03 California Institute Of Technology Unnatural amino acid containing display libraries
JP2008506703A (ja) 2004-07-14 2008-03-06 ユニバーシティ オブ ユタ リサーチ ファウンデーション ネトリン関連化合物および用途
WO2006101273A1 (ja) * 2005-03-25 2006-09-28 Takeda Pharmaceutical Company Limited 癌の予防・治療剤
AU2006313464B2 (en) * 2005-11-11 2012-07-12 Proteogen Bio S.R.L. Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
CN101952306B (zh) * 2008-02-21 2014-09-10 皮护神经科学协会 Mntf肽的化妆和皮肤病制剂
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924754B (zh) * 2015-12-30 2021-11-09 北京大学 聚氨基酸偶联物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
KR102710762B1 (ko) 2017-10-25 2024-09-25 얀센 파마슈티칼즈, 인코포레이티드 인산화 타우 펩티드의 조성물 및 이의 용도
AU2020219804A1 (en) 2019-02-08 2021-08-19 Ac Immune S.A. Method of safe administration of phosphorylated Tau peptide vaccine
JP2023136614A (ja) * 2022-03-17 2023-09-29 三菱ケミカル株式会社 植物を用いたヘッジホッグタンパク質の製造方法
CN116983461B (zh) * 2023-03-14 2025-07-22 中国石油大学(华东) 基于脂质体修饰的止血海绵体系
CN116549713B (zh) * 2023-05-09 2025-06-13 浙江大学 一种兼具组织粘合和防粘连的手术贴片和其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
EP0966478A4 (en) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
KR20010032753A (ko) 1997-12-03 2001-04-25 온토제니, 인코오포레이티드 소수적으로 개질된 단백질 조성물 및 방법

Also Published As

Publication number Publication date
DE69830192T2 (de) 2006-01-12
KR20010032753A (ko) 2001-04-25
AU1996699A (en) 1999-06-16
WO1999028343A9 (en) 1999-10-14
HUP0100535A2 (hu) 2001-06-28
EA200000605A1 (ru) 2000-12-25
JP2001525336A (ja) 2001-12-11
TR200001612T2 (tr) 2001-01-22
WO1999028343A3 (en) 1999-08-12
IL136137A (en) 2009-09-22
DE69830192D1 (de) 2005-06-16
BR9815142A (pt) 2000-10-10
WO1999028343A2 (en) 1999-06-10
JP4289788B2 (ja) 2009-07-01
EE200000308A (et) 2001-10-15
CN1294595A (zh) 2001-05-09
EP1036092B1 (en) 2005-05-11
HK1030953A1 (en) 2001-05-25
PL197833B1 (pl) 2008-04-30
US6444793B1 (en) 2002-09-03
EP1036092A2 (en) 2000-09-20
PT1036092E (pt) 2005-09-30
PL341430A1 (en) 2001-04-09
IS2163B (is) 2006-11-15
CZ20002008A3 (cs) 2001-11-14
ES2243018T3 (es) 2005-11-16
NO20002789D0 (no) 2000-05-31
IS5499A (is) 2000-05-15
NZ504752A (en) 2002-10-25
EA003739B1 (ru) 2003-08-28
CA2309806A1 (en) 1999-06-10
MXPA00005494A (es) 2003-05-19
ATE295372T1 (de) 2005-05-15
NO20002789L (no) 2000-08-02
HUP0100535A3 (en) 2003-09-29
AU757497B2 (en) 2003-02-20
DK1036092T3 (da) 2005-08-15

Similar Documents

Publication Publication Date Title
IL136137A0 (en) Hydrophobically-modified protein compositions and methods
De Caro et al. Porcine pancreatic lipase. Completion of the primary structure
Pleau et al. Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence.
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
AR004860A1 (es) Anticuerpos mono o policionales, anticuerpos conjugados, o sus fragmentos, su utilizacion y metodo de diagnostico in vitro de patologias correlacionadas con una expresion anormal del receptor de la il-13, a partir de muestras biologicas susceptibles de contener el receptor de la il-13 expresado a un nivel anormal
EP1712623A3 (en) Selection of proteins using RNA-protein fusions
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
WO2001075087A3 (en) Subtilisin variants
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
WO1999006557A3 (en) Mammalian cell membrane proteins; related reagents
WO2000000600A3 (en) Lentiviral vectors, comprising modified major donor splice sites and major packaging signals
EP2305818A3 (en) Antigen constructs useful in the detection and differentiation of antibodies to HIV
WO1999028876A3 (en) Hydrophobically-modified protein compositions and methods
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
WO2002012541A3 (en) Novel motor proteins and methods for their use
AU2001235894A1 (en) Novel mammalian secreted group iii phospholipase a2
WO2002079479A3 (en) Motor proteins and methods for their use
WO2000034335A3 (en) 'death domain' containing receptors
AU1779088A (en) Guanidine-related compounds comprising a tetraphenylborate ion, process for obtaining these compounds and use of the compounds in peptide synthesis
WO2001025430A3 (en) Novel human membrane proteins
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок